Groundbreaking procedure offers new hope for Alzheimer’s disease
Barrow Neurological Institute first to conduct trial in international study A groundbreaking procedure that offers new hope for patients with Alzheimer’s disease is being tested at Barrow Neurological Institute in Phoenix. The largest international trial to date will evaluate the safety and effectiveness of Deep Brain Stimulation (DBS) in patients over 65 years old with mild probable Alzheimer’s, and it will test the hypothesis that DBS will slow cognitive decline related to Alzheimer’s. The DBS procedure has provided remarkable therapeutic benefits for otherwise treatment-resistant movement disorders such as Parkinson’s disease and essential tremor. The delicate procedure involves placing one or…